MedTech Innovator last week announced the five finalists for its $500,000 competition. The organization will award more than $500,000 in prizes to the finalists with first place taking $350,000 and the four remaining finalists taking $25,000. Five finalists will have seven minutes to pitch their technologies to a panel of four judges. The audience will […]
Diagnostics
Eitan Group inks Canadian distribution deal for Sapphire infusion pumps
Eitan Group today announced it signed a distribution agreement with Canadian Hospital Specialities to distribute its Sapphire infusion pumps in Canada. Through the agreement, Canadian Hospital Specialties will supply and support Israel-based Eitan Group’s Sapphire infusion pumps to hospitals and alternate site customers in Canada. Get the full story on our sister site, Drug Delivery Business.
DreaMed wins clearance, CE Mark for AI-powered insulin dosing software
DreaMed Diabetes today said it received FDA 510(k) clearance and CE Mark approval for its DreaMed Advisor Pro software. DreaMed Advisor Pro is an AI-based insulin dosing decision supply software designed for people with Type 1 diabetes using insulin pump therapy with continuous glucose sensors or blood glucose meters. The software previously received CE Mark approval […]
Abbott, Medtronic ink diabetes pacts with Sanofi, Novo Nordisk
Abbott (NYSE:ABT) and Medtronic (NYSE:MDT) today announced separate data-sharing deals for digital diabetes management solutions. Abbott is partnering with Sanofi (NYSE:SNY) to integrate glucose sensing and insulin delivery to help people manage their diabetes. The two companies plan to develop tools to combine Abbott’s FreeStyle Libre technology with insulin dosing information for smart pens, insulin titration apps and cloud software. […]
T2 Biosystems jumps on $69m BARDA deal
T2 Biosystems (NSDQ:TTOO) this week said that it inked an up to $69 million diagnostics deal with a U.S. Defense Dept. research program. Lexington, Mass.-based T2 Biosystems signed a maximum $69 million funding deal with the Health and Human Services Office of the Assistant Secretary for Preparedness and Response’s Biomedical Advanced Research & Development Authority for […]
Bayer launches contrast agent injector
Bayer (ETR:BAYN) yesterday said that it has launched its Medrad Stellant Flex CT injection system. Stellant Flex is a user-driven system that requires minimal technologist training and automation, according to Whippany, N.J.-based Bayer U.S. It offers individualized patient protocols and personalized imaging with flexible options for capital equipment through the company’s TechCare program. “For more than […]
Healthy.io raises $60m in Series C funding round
Healthy.io said today that it completed a Series C financing round worth $60 million and won FDA 510(k) clearance for its smartphone-based ACR test. The funding round was led by Corner Ventures and Joy Capital, as well as previous investors Ansonia Holdings, Aleph and Samsung NEXT. The Tel Aviv, Israel-based company plans to use the […]
PerkinElmer prices $850m offering
PerkinElmer (NYSE:PKI) yesterday priced a stock offering of $850 million. The offering consists of 3.3% senior notes due in 2029 at an issue price of 99.67% of the principal amount. PerkinElmer said it expects to complete the offering on Sept. 12, and that the notes will pay interest on a semi-annual basis. Waltham, Mass.-based PerkinElmer said […]
iRhythm closes $115m offering
iRhythm Technologies (NSDQ:IRTC) said yesterday that it closed its underwritten public offering of common stock for gross proceeds exceeding $100 million. The San Fransisco-based company said it offered nearly 1.6 million shares at $73 per share, including the exercise in full of the underwriters’ option to purchase an additional 205,479 shares. iRhythm initially estimated net proceeds […]
These 5 DIY medical devices might surprise you
Big ideas in medical device development can come from regular people driven to solve vexing problems. Here are a handful of folks from outside the medtech industry who decided to create devices to solve their own health troubles or those of others around the world. Read on to see what high school, college and medical […]
Bio-Rad beats expectations on Q2 results
Bio-Rad Laboratories (NYSE:BIO) posted second-quarter earnings this evening that beat the consensus forecast on Wall Street. The Hercules, Calif.–based life science research and clinical diagnostics manufacturer reported profits of $598.8 million, or $19.86 per share, on sales of $572.6 million for the three months ended June 30, for the bottom-line more than doubling and sales slightly declining compared […]